FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2807372259> ?p ?o ?g. }

• W2807372259 abstract "The present study aimed to explore the role and clinical value of the detection of Excision repair cross‑complementing 1(ERCC1) C8092A polymorphisms in individualized therapy of patients with advanced esophageal cancer. A total of 127 patients with advanced esophageal cancer were enrolled between January 2010 and January 2014 in Anhui Provincial Hospital. Patients were randomly assigned in a 1:2 ratio to a standard treatment group or an individualized treatment group, respectively, prior to ERCC1 C8092A assessment. Patients in the standard treatment group were treated with paclitaxel and cisplatin. The DNA was obtained from the peripheral blood of individualized treatment patients, amplified by PCR and sequenced to determine the ERCC1 C8092A polymorphism prior to the administration of chemotherapies. Patients with the ERCC1 C8092A genotype of A/A or A/C received paclitaxel and cisplatin, and those with the genotype of C/C received paclitaxel and fluorouracil. The primary endpoint was response rate (RR). The secondary endpoints included toxicity of chemotherapy, progression‑free survival (PFS) and overall survival (OS) times. Differences between the groups were evaluated by χ2 test. Differences in survival were analyzed by Kaplan‑Meier survival curves. The survival rate was analyzed by log‑rank test. Follow‑up data was obtained until December 2015. The RR was obtained for 15 patients (34.8%) in the standard treatment group and 45 patients (53.6%) in the individualized treatment group (χ2=3.095; P=0.046). For adverse events, nausea and vomiting and anemia were significantly decreased in the individualized treatment group compared with the standard treatment group (P=0.001 and P=0.004, respectively). The median progression free survival time was 4.4 months [95% confidence interval (CI)3.8‑5.0 months] in the standard treatment group and 6.6 months (95% CI, 5.8‑7.4 months) in the individualized treatment group (P=0.018). The median overall survival time was 11.4 months (95% CI, 10.1‑12.7 months) in the standard treatment group and 14.2 months (95% CI, 13.2‑15.2 months) in the individualized treatment group (P=0.008). The RR, toxicity of chemotherapy, PFS and OS were significantly improved in the individualized treatment group compared with the standard treatment group. Detection of ERCC1 gene polymorphisms maybe performed for patients with advanced esophageal cancer to improve individualized therapy, which requires additional study." @default.
• W2807372259 created "2018-06-13" @default.
• W2807372259 creator A5010417032 @default.
• W2807372259 creator A5036613051 @default.
• W2807372259 creator A5061084006 @default.
• W2807372259 creator A5064067694 @default.
• W2807372259 creator A5073346815 @default.
• W2807372259 date "2018-06-04" @default.
• W2807372259 modified "2023-10-01" @default.
• W2807372259 title "Clinical research of individualized therapy in advanced esophageal cancer based on the ERCC1 C8092A genotype" @default.
• W2807372259 cites W1708078964 @default.
• W2807372259 cites W1986679409 @default.
• W2807372259 cites W1987604182 @default.
• W2807372259 cites W1987902378 @default.
• W2807372259 cites W1989212292 @default.
• W2807372259 cites W1990404871 @default.
• W2807372259 cites W1993406455 @default.
• W2807372259 cites W1999358239 @default.
• W2807372259 cites W2019607817 @default.
• W2807372259 cites W2024489444 @default.
• W2807372259 cites W2027321342 @default.
• W2807372259 cites W2040644913 @default.
• W2807372259 cites W2041560748 @default.
• W2807372259 cites W2044346962 @default.
• W2807372259 cites W2061273409 @default.
• W2807372259 cites W2062012958 @default.
• W2807372259 cites W2080932017 @default.
• W2807372259 cites W2086501419 @default.
• W2807372259 cites W2089708226 @default.
• W2807372259 cites W2107277218 @default.
• W2807372259 cites W2142519649 @default.
• W2807372259 cites W2143384044 @default.
• W2807372259 cites W2148725710 @default.
• W2807372259 cites W2164814325 @default.
• W2807372259 cites W2164904189 @default.
• W2807372259 cites W2169035956 @default.
• W2807372259 cites W2173751778 @default.
• W2807372259 cites W2192080449 @default.
• W2807372259 cites W2285955673 @default.
• W2807372259 cites W2318966999 @default.
• W2807372259 cites W2395739137 @default.
• W2807372259 cites W2534492915 @default.
• W2807372259 cites W2587594625 @default.
• W2807372259 cites W2776863732 @default.
• W2807372259 cites W1554814573 @default.
• W2807372259 doi "https://doi.org/10.3892/ol.2018.8894" @default.
• W2807372259 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6036568" @default.
• W2807372259 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30013648" @default.
• W2807372259 hasPublicationYear "2018" @default.
• W2807372259 type Work @default.
• W2807372259 sameAs 2807372259 @default.
• W2807372259 citedByCount "1" @default.
• W2807372259 countsByYear W28073722592019 @default.
• W2807372259 crossrefType "journal-article" @default.
• W2807372259 hasAuthorship W2807372259A5010417032 @default.
• W2807372259 hasAuthorship W2807372259A5036613051 @default.
• W2807372259 hasAuthorship W2807372259A5061084006 @default.
• W2807372259 hasAuthorship W2807372259A5064067694 @default.
• W2807372259 hasAuthorship W2807372259A5073346815 @default.
• W2807372259 hasBestOaLocation W28073722591 @default.
• W2807372259 hasConcept C104317684 @default.
• W2807372259 hasConcept C104451858 @default.
• W2807372259 hasConcept C121608353 @default.
• W2807372259 hasConcept C126322002 @default.
• W2807372259 hasConcept C134935766 @default.
• W2807372259 hasConcept C143998085 @default.
• W2807372259 hasConcept C168563851 @default.
• W2807372259 hasConcept C203092338 @default.
• W2807372259 hasConcept C2776694085 @default.
• W2807372259 hasConcept C2778239845 @default.
• W2807372259 hasConcept C2779309665 @default.
• W2807372259 hasConcept C2779742542 @default.
• W2807372259 hasConcept C2780580376 @default.
• W2807372259 hasConcept C55493867 @default.
• W2807372259 hasConcept C71924100 @default.
• W2807372259 hasConcept C86803240 @default.
• W2807372259 hasConcept C90924648 @default.
• W2807372259 hasConceptScore W2807372259C104317684 @default.
• W2807372259 hasConceptScore W2807372259C104451858 @default.
• W2807372259 hasConceptScore W2807372259C121608353 @default.
• W2807372259 hasConceptScore W2807372259C126322002 @default.
• W2807372259 hasConceptScore W2807372259C134935766 @default.
• W2807372259 hasConceptScore W2807372259C143998085 @default.
• W2807372259 hasConceptScore W2807372259C168563851 @default.
• W2807372259 hasConceptScore W2807372259C203092338 @default.
• W2807372259 hasConceptScore W2807372259C2776694085 @default.
• W2807372259 hasConceptScore W2807372259C2778239845 @default.
• W2807372259 hasConceptScore W2807372259C2779309665 @default.
• W2807372259 hasConceptScore W2807372259C2779742542 @default.
• W2807372259 hasConceptScore W2807372259C2780580376 @default.
• W2807372259 hasConceptScore W2807372259C55493867 @default.
• W2807372259 hasConceptScore W2807372259C71924100 @default.
• W2807372259 hasConceptScore W2807372259C86803240 @default.
• W2807372259 hasConceptScore W2807372259C90924648 @default.
• W2807372259 hasLocation W28073722591 @default.
• W2807372259 hasLocation W28073722592 @default.
• W2807372259 hasLocation W28073722593 @default.
• W2807372259 hasLocation W28073722594 @default.
• W2807372259 hasOpenAccess W2807372259 @default.
• W2807372259 hasPrimaryLocation W28073722591 @default.

• next